IBEX — IBEX Limited

IBEX Limited Q3 FY 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: $164.4 million, a 17% increase from $140.7 million in Q3 FY 2025.
• Adjusted EPS: $0.91, up 11% from $0.82 in the prior year.
• Net Income: $13.3 million, compared to $10.5 million in Q3 FY 2025.
• Adjusted EBITDA: $22 million (13.4% of revenue), a record high, although slightly down from 13.8% in the prior year.
• Client Retention: 100% for the quarter, with a revenue retention rate of 99.9% for the year.
• Cash Flow: Net cash from operations was $11.9 million, up from $8.8 million in the prior year.

2. Strategic Updates and Business Highlights

• Growth Drivers: Strong performance in the health tech vertical (54% growth), technology (42.6%), and travel/logistics (15.1%).
• New Client Wins: 11 new logos year-to-date, with significant growth from existing clients, particularly in health care.
• Partnership with Sierra AI: A strategic collaboration to integrate AI technology into IBEX's customer experience solutions, expected to enhance operational capabilities and revenue growth.
• Market Positioning: IBEX is transitioning from a traditional BPO model (BPO 1.0) to a more differentiated model (BPO 2.0), focusing on technology and customer experience.

3. Forward Guidance and Outlook

• Revenue Guidance: Raised to $638-$642 million for FY 2026, up from $620-$630 million.
• Adjusted EBITDA Guidance: Increased to $82-$84 million, up from $80-$82 million.
• Capital Expenditures: Expected to be $25-$30 million, up from $20-$25 million, reflecting investments in higher-margin areas.

4. Bad News, Challenges, or Points of Concern

• Severance Expenses: $0.8 million incurred due to a client shifting volumes, with an anticipated asset impairment charge in Q4.
• Declining Metrics in Telecommunications: A notable 23.1% decline in this vertical, which is one of the smaller segments for IBEX.
• Market Perception: The broader BPO industry faces challenges from generative AI, which may impact traditional call center volumes, although IBEX is positioning itself to leverage AI as an opportunity rather than a threat.

5. Notable Q&A Insights

• AI Partnership Model: CEO Bob Dechant clarified that IBEX will maintain its own contracts while leveraging Sierra's technology, which is expected to enhance margins significantly.
• Sustainability of Growth: Management confirmed that the 54% growth in health care is sustainable, driven by both new client acquisitions and market share gains from existing clients.
• Operational Efficiency: The company has improved its operational structure, leading to smoother revenue flows without significant seasonal fluctuations, contrasting with historical performance.

Overall, IBEX Limited reported strong financial results and strategic advancements, particularly with the integration of AI technology, while also addressing challenges in certain verticals and the broader industry landscape.